Log In
Print
BCIQ
Print
Print this Print this
 

Aes-103, 5-hydroxymethyl-2-furfural

  Manage Alerts
Collapse Summary General Information
Company Baxter International Inc.
DescriptionAromatic aldehyde that increases the affinity of sickle hemoglobin for oxygen
Molecular Target Hemoglobin
Mechanism of ActionAllosteric modulator of hemoglobin
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationSickle cell disease
Indication DetailsTreat sickle cell disease
Regulatory Designation

U.S. - Orphan Drug (Treat sickle cell disease)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today